Connor Clark & Lunn Investment Management Ltd. Makes New $284,000 Investment in Tempus AI, Inc. $TEM

Connor Clark & Lunn Investment Management Ltd. bought a new stake in Tempus AI, Inc. (NASDAQ:TEM) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 4,467 shares of the company’s stock, valued at approximately $284,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Concord Wealth Partners increased its holdings in shares of Tempus AI by 308.0% in the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company’s stock worth $26,000 after acquiring an additional 308 shares during the period. Sigma Planning Corp increased its stake in shares of Tempus AI by 1.0% in the second quarter. Sigma Planning Corp now owns 33,834 shares of the company’s stock valued at $2,150,000 after purchasing an additional 319 shares during the period. Farther Finance Advisors LLC raised its holdings in shares of Tempus AI by 59.9% during the second quarter. Farther Finance Advisors LLC now owns 884 shares of the company’s stock valued at $56,000 after buying an additional 331 shares during the last quarter. Axxcess Wealth Management LLC boosted its position in shares of Tempus AI by 6.2% during the second quarter. Axxcess Wealth Management LLC now owns 8,190 shares of the company’s stock worth $520,000 after buying an additional 481 shares during the period. Finally, SouthState Corp grew its holdings in Tempus AI by 3,761.5% in the 2nd quarter. SouthState Corp now owns 502 shares of the company’s stock worth $32,000 after buying an additional 489 shares in the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

Insider Buying and Selling

In related news, COO Ryan Fukushima sold 10,099 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $65.54, for a total transaction of $661,888.46. Following the transaction, the chief operating officer directly owned 829,081 shares of the company’s stock, valued at approximately $54,337,968.74. The trade was a 1.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erik Phelps sold 3,533 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total transaction of $231,552.82. Following the completion of the sale, the executive vice president owned 90,582 shares of the company’s stock, valued at approximately $5,936,744.28. The trade was a 3.75% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 1,225,264 shares of company stock valued at $95,497,911. 26.27% of the stock is currently owned by company insiders.

Tempus AI Stock Performance

NASDAQ:TEM opened at $65.69 on Friday. The company has a 50-day moving average of $83.96 and a 200-day moving average of $71.87. The firm has a market cap of $11.69 billion, a price-to-earnings ratio of -55.20 and a beta of 4.86. The company has a current ratio of 3.28, a quick ratio of 3.12 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a twelve month low of $31.36 and a twelve month high of $104.32.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The company had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. During the same quarter in the prior year, the firm earned ($0.46) EPS. The company’s quarterly revenue was up 84.7% compared to the same quarter last year. Tempus AI has set its FY 2025 guidance at EPS. Analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Cowen lowered Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. TD Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price objective for the company. in a report on Tuesday, October 21st. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Piper Sandler dropped their price target on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 11th. Finally, Canaccord Genuity Group decreased their price objective on shares of Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Tempus AI currently has an average rating of “Hold” and an average target price of $80.00.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.